This is a disclosure report regarding direct/indirect conflicts of interest of a financial, functional or any other nature related to commercial and non-commercial organizations.
Commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature
- CEO of Ymmunobio AG, start up company in immune oncology
- Independent board member Ambrx Inc., biotech company developing ADCs in diffrent therapeutic areas
- Independent board member Zyversa developing products in immunology and renal diseases
Non-commercial organizations with actual/potential/perceived conflict of interest of a financial/functional/any other nature
- None
Last updated on 20 April 2023